Table 2.
Final round 3 voting on ten rheumatoid arthritis–specific key performance indicators for centralized intake
| Median (range) and percentage of participants voting ≥7 on 1–9 scale for each domain (n = 23 unless otherwise specified) | |||||
|---|---|---|---|---|---|
| Scientific validity | Face validity | Feasibility: information availability | Importance | Likelihood of use | |
| KPI 2: Time from RA referral receipt to referral completion for initially incomplete referrals | 7 (5–8), 61 % | 7 (6–8), 74 % | 8 (6–8), n = 22 (64 %) | 8 (7–8), 78 % | 7 (6–8), 65 % |
| KPI 4: Percentage of RA referrals received with complete information | 7 (7–8), 78 % | 8 (7–8), 83 % | 7 (6–8), n = 22 (59 %) | 8 (7–8), n = 22 (82 %) | 7 (6–8), n = 22 (68 %) |
| KPI 6: Waiting times for rheumatologist consultation for patients with new-onset rheumatoid arthritis | N/Aa | N/Aa | 8 (8–9), n = 21 (95 %) | 9 (8–9), n = 22 (100 %) | 9 (9–9), n = 22 (100 %) |
| KPI 7: Time to disease-modifying antirheumatic drug therapy for patients with new-onset RA | N/Aa | N/Aa | 7 (6–8), n = 22 (68 %) | 9 (8–9), 91 % | 9 (8–9), n = 22 (100 %) |
| KPI 8: Percentage of patients with new-onset RA with at least one visit to a rheumatologist in the first year of diagnosis | N/Aa | N/Aa | 7 (6–8), n = 21 (57 %) | 8 (7–9), 78 % | 8 (7–8), 83 % |
| KPI 10: Rheumatologists per 100,000 population | N/Aa | N/Aa | 7 (6–8), n = 21 (62 %) | 7 (6–7), n = 22 (59 %) | 7 (5–7), n = 21 (52 %) |
| KPI 17: Waiting times for patients with established RA | 8 (8–9), 96 % | 9 (8–9), 96 % | 8 (7–8), n = 22 (77 %) | 8 (8–9), 91 % | 8 (8–9), 96 % |
| KPI 18: Percentage of rheumatoid arthritis patients treated with a disease-modifying antirheumatic drug during the measurement year | N/Aa | N/Aa | 8 (6–9), 70 % | 8 (8–9), 83 % | 9 (8–9), 83 % |
| KPI 28: Ratio of patient flow to clinic capacity of RA teams participating in centralized intake | 7 (6–8), n = 22 (73 %) | 8 (7–8), n = 22 (82 %) | 7 (5–8), n = 22 (55 %) | 7 (7–8), 83 % | 8 (7–9), n = 22 (86 %) |
| KPI 31: Agreement of centralized intake suspected diagnosis versus confirmed diagnosis of RA | 8 (6–8), n = 21 (71 %) | 8 (6–8), 74 % | 7 (5–8), n = 22 (55 %) | 8 (7–9), n = 22 (86 %) | 8 (7–9), n = 21 (76 %) |
RA rheumatoid arthritis
aKey performance indicators (KPIs) 6, 7, 8, 10 and 18 were harmonized with the Arthritis Alliance of Canada performance measure set for inflammatory arthritis which used a similar process for development and scientific validity and face validity were not examined again in the present study